Since establishing direct local sales operations in 2025, Sisram has secured deep roots within Thailand’s premium aesthetics clinics. The rollout of the Soprano Titanium is supported by the continued success of Profhilo, which has maintained strong momentum among practitioners focused on skin remodeling and facial contouring. By integrating these two distinct business lines, the firm is encouraging clinics to adopt comprehensive treatment protocols that combine device-based tightening with injectable rejuvenation.

CEO Eyal Ben David noted that the company’s recent performance validates its localized operating model. Sisram plans to use the Thai market as a strategic anchor for the wider APAC region, with a pipeline of additional energy-based devices currently awaiting regulatory approval for release in late 2026. This expansion includes a commitment to scaled-up medical education and technical support, designed to deepen product penetration and improve revenue consistency across the company’s regional network.